Core Insights - The company reported a total operating revenue of 327 million yuan for the fiscal year 2025, representing a year-on-year growth of 19.96% [1] - The net profit reached 84.09 million yuan, showing a significant increase of 62.04% compared to the previous year [1] Revenue and Profit Growth - The revenue growth is attributed to the company's innovation-driven strategy and a dual domestic and international market approach [1] - The sales revenue from endoscopic staplers continued to grow steadily during the reporting period [1] Cost Optimization and Profitability - The company experienced an increase in gross profit margin year-on-year, which contributed to the overall profit increase [1] - The scale effect of products and cost optimization strategies played a crucial role in enhancing profitability [1]
天臣医疗:2025年净利润同比增长62.04%